Kolisin Neo Escherichia coli inaktywowany szczep F4 RP ≥ 1Escherichia coli inaktywowany szczep F5 RP ≥ 1Escherichia coli inaktywowany szczep F6 RP ≥ 1Escherichia coli inaktywowany szczep F41 RP ≥ 1RP - względna moc oznaczona metodą ELISA

Przegląd produktu

About Kolisin Neo Escherichia coli inaktywowany szczep F4 RP ≥ 1Escherichia coli inaktywowany szczep F5 RP ≥ 1Escherichia coli inaktywowany szczep F6 RP ≥ 1Escherichia coli inaktywowany szczep F41 RP ≥ 1RP - względna moc oznaczona metodą ELISA

Kolisin Neo Escherichia coli inaktywowany szczep F4 RP ≥ 1Escherichia coli inaktywowany szczep F5 RP ≥ 1Escherichia coli inaktywowany szczep F6 RP ≥ 1Escherichia coli inaktywowany szczep F41 RP ≥ 1RP - względna moc oznaczona metodą ELISA is identified as a medicine. The supplied product information specifies inactivated Escherichia coli strains F4, F5, F6, and F41. The stated specification for each strain is a relative potency of at least 1 RP. RP means relative potency determined by the ELISA method. No additional information about the product presentation, route of administration, target species, indication, or treatment schedule is provided.

Key Benefits & Uses

• Contains the inactivated Escherichia coli strains identified as F4, F5, F6, and F41 in the product name.
• Lists a relative potency of at least 1 RP for each specified strain.
• Uses ELISA as the stated method for determining relative potency.

Active Ingredient & Action

The supplied facts do not separately state an active ingredient or describe a clinical mechanism of action. The product name identifies inactivated Escherichia coli strains F4, F5, F6, and F41, with relative potency measured by ELISA.

Important Notes

No dosage, administration instructions, contraindications, adverse effects, storage conditions, or specific uses were supplied. Consult the official product information or a qualified healthcare professional before use.